MoonLake Capital Surpluse vs Accounts Payable Analysis
| MLTX Stock | USD 54.43 0.19 0.35% |
MoonLake Immunotherapeuti financial indicator trend analysis is infinitely more than just investigating MoonLake Immunotherapeuti recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether MoonLake Immunotherapeuti is a good investment. Please check the relationship between MoonLake Immunotherapeuti Capital Surpluse and its Accounts Payable accounts. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in MoonLake Immunotherapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.
Capital Surpluse vs Accounts Payable
Capital Surpluse vs Accounts Payable Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of MoonLake Immunotherapeuti Capital Surpluse account and Accounts Payable. At this time, the significance of the direction appears to have strong relationship.
The correlation between MoonLake Immunotherapeuti's Capital Surpluse and Accounts Payable is 0.62. Overlapping area represents the amount of variation of Capital Surpluse that can explain the historical movement of Accounts Payable in the same time period over historical financial statements of MoonLake Immunotherapeutics, assuming nothing else is changed. The correlation between historical values of MoonLake Immunotherapeuti's Capital Surpluse and Accounts Payable is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Capital Surpluse of MoonLake Immunotherapeutics are associated (or correlated) with its Accounts Payable. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Accounts Payable has no effect on the direction of Capital Surpluse i.e., MoonLake Immunotherapeuti's Capital Surpluse and Accounts Payable go up and down completely randomly.
Correlation Coefficient | 0.62 |
| Relationship Direction | Positive |
| Relationship Strength | Significant |
Capital Surpluse
Accounts Payable
An accounting item on the balance sheet that represents MoonLake Immunotherapeuti obligation to pay off a short-term debt to its creditors. The accounts payable entry is usually reported under current liabilities. If accounts payable of MoonLake Immunotherapeuti are not paid within the agreed terms, the payables are considered to be in default, which may trigger a penalty or interest payment, or the revocation of additional credit from the supplier. Accounts payable may also be considered a source of cash, since they represent funds being borrowed from suppliers. Given these cash flow considerations, suppliers have a natural inclination to push for shorter payment terms, while creditors want to lengthen the payment terms. The amount a company owes to suppliers or vendors for products or services received but not yet paid for. It represents the company's short-term liabilities.Most indicators from MoonLake Immunotherapeuti's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into MoonLake Immunotherapeuti current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in MoonLake Immunotherapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. Enterprise Value is likely to rise to about 2.6 B in 2024, whereas Selling General Administrative is likely to drop slightly above 18.3 M in 2024.
| 2021 | 2022 | 2023 | 2024 (projected) | Other Operating Expenses | 4.6M | 65.1M | 54.1M | 34.1M | Depreciation And Amortization | 5.0K | 12.4K | 13.2K | 12.5K |
MoonLake Immunotherapeuti fundamental ratios Correlations
Click cells to compare fundamentals
MoonLake Immunotherapeuti Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for MoonLake Stock Analysis
When running MoonLake Immunotherapeuti's price analysis, check to measure MoonLake Immunotherapeuti's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy MoonLake Immunotherapeuti is operating at the current time. Most of MoonLake Immunotherapeuti's value examination focuses on studying past and present price action to predict the probability of MoonLake Immunotherapeuti's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move MoonLake Immunotherapeuti's price. Additionally, you may evaluate how the addition of MoonLake Immunotherapeuti to your portfolios can decrease your overall portfolio volatility.